Memphasys Ltd

MEM

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

Progress in UK expansion for undervalued ASX share

Guidance reaffirmed and UK implementation on track.
stocks

The sectors set to soar on government spending

Governments worldwide love to spend more money, and there are no signs that it will change any time soon.
stocks

Chart of the Week: How private companies are reshaping public markets

Our latest take from the US Manager Research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,098.609.70-0.11%
CAC 408,026.2048.03-0.59%
DAX 4024,004.8544.89-0.19%
Dow JONES (US)47,311.00225.760.48%
FTSE 1009,778.121.040.01%
HKSE26,485.90550.492.12%
NASDAQ23,499.80151.160.65%
Nikkei 22550,883.68671.411.34%
NZX 50 Index13,576.8144.17-0.32%
S&P 5006,796.2924.740.37%
S&P/ASX 2008,828.308.50-0.10%
SSE Composite Index4,007.7638.510.97%

Market Movers